Stay updated on Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial page.

Latest updates to the Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial page
- Check6 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, representing a minor update to the page history system.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedA new version entry (Version 41) was added to the study's record history with a submission date of 2026-05-07 and a Revision: v3.5.4. The prior Revision: v3.5.3 entry, dated 2026-01-30, was removed from the history.SummaryDifference0.3%

- Check42 days agoChange DetectedA new revision entry v3.5.3 was added to the study's record history, and the previous revision v3.5.2 was removed. This updates the visible version history to reflect the latest page revision.SummaryDifference0.1%

- Check56 days agoChange DetectedAdded revision v3.5.2 and removed revision v3.5.0 from the history.SummaryDifference0.1%

- Check85 days agoChange DetectedRevision v3.5.0 was added and revision v3.4.3 was removed from the page history.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision v3.4.3 has been added and revision v3.4.2 has been removed from the history.SummaryDifference0.1%

Stay in the know with updates to Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial page.